Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.
Henan Cancer Hospital
Henan Cancer Hospital
Institut Paoli-Calmettes
Institut fuer Frauengesundheit
Peking Union Medical College Hospital
Fujian Medical University
Zhejiang Cancer Hospital
Fudan University
Immunicom Inc
Shengjing Hospital
Peking University Cancer Hospital & Institute
OmicsWay Corp.
University of Florence
Tianjin Medical University Cancer Institute and Hospital
Beni-Suef University
Federation of Breast Diseases Societies
Zhejiang Cancer Hospital
Fudan University
Academic Emergency County Hospital Sibiu
Shenzhen People's Hospital
National Cancer Center, Korea
ChineseAMS
Medifocus, Inc.
Genentech, Inc.
Asan Medical Center
National Cancer Institute (NCI)
Auxilio Mutuo Cancer Center